About TechBridge

With a solid footing in the technology transfer sector since 2018, our expertise has been a cornerstone in bridging the gap between groundbreaking innovations and lucrative market opportunities. Initially serving the BioInvestment Group, formerly known as Sensyo, we have meticulously evaluated the potential of novel technologies, ensuring a seamless transition from ideation to market realization. Our role transcends mere evaluation – we sculpt the business case, tailoring a pathway that aligns the technological prowess with market demands and investor expectations.

 

Our journey has propelled us across the global stage, engaging with governmental bodies, orchestrating substantial business-to-business transactions, and fostering a robust network of international partners within the technology transfer ecosystem. This extensive engagement has not only honed our acumen but has positioned us at the frontline of understanding the diverse needs and opportunities that span across innovators, investors, and service providers.

 

To heighten the efficiency and scope of technology transfer, we have harnessed the power of Artificial Intelligence (AI) and human-centered thinking. By integrating AI automation and HCD, we have pioneered a global marketplace that transforms the business case for innovation. This avant-garde platform is a nexus where the triad of innovators, investors, and service partners converge, unleashing a wellspring of opportunities and accelerating the global technology transfer landscape. 

 

Through this initiative, we continue to bolster the commercialization of innovations, underscoring our commitment and proficiency in driving the technology transfer agenda forward.